Sacramento, CA11 Active Studies

Essential Tremor Clinical Trials in Sacramento, CA

Find 11 actively recruiting essential tremor clinical trials in Sacramento, CA. Connect with local research sites and explore new treatment options.

11
Active Trials
9
Sponsors
4,055
Enrolling

Recruiting Essential Tremor Studies in Sacramento

About Essential Tremor Clinical Trials in Sacramento

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 11 essential tremor clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 4,055 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Vertex Pharmaceuticals Incorporated, Medtronic MiniMed, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Sacramento — FAQ

Are there essential tremor clinical trials in Sacramento?

Yes, there are 11 essential tremor clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 11 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 17, 2026 from ClinicalTrials.gov